Experts suggest that generative AI models in medicine should be licensed similarly to doctors and nurses to ensure accountability and safety.
Key Details
- 1Academic, policy, and public health leaders propose a licensure framework for medical GenAI models, similar to those for clinicians.
- 2UPenn's Eric Bressman and collaborators published a JAMA Internal Medicine opinion highlighting this approach.
- 3A blog post by UPenn policy expert Julia Hinkley supports a federal digital licensing board overseeing medical AI.
- 4FDA could handle premarket review, while state boards might provide ongoing oversight and coordinate standards.
- 5The initiative aims to address concerns about AI hallucinations, performance drift, and maintain standards and accountability.
Why It Matters
As generative AI’s use grows in radiology and other areas, robust and harmonized regulation is critical to maintain quality, safety, and trust. Introducing a licensing system modeled after medical professions could help set clear expectations and mechanisms for oversight of clinical AI systems.
Source
HealthExec
Related News
•HealthExec
AI Reimbursement, Biomedical Research, and Exec Survey Highlight Healthcare Trends
Healthcare AI adoption is rising, but ROI measurement and clinical impact remain key challenges.
•HealthExec
Senate Vote Fails to Block AI Medicare Prior Authorization Pilot
A Senate vote failed to halt the WISeR AI-based prior authorization pilot for traditional Medicare claims.
•HealthExec
Mayo Clinic Sued Over Alleged AI Improprieties and Whistleblower Retaliation
A former Mayo Clinic research director sues the institution, alleging retaliation after raising concerns about improper AI use affecting patient safety and data integrity.